Global Bioactive Glass Market, By Type (45S5, S53P4, and Others), Application (Orthopaedics, Dentistry, Cosmetics, and Others), Industry Vertical (Medical, Dental, and Cosmetics), Synthesis Process (Melt Quench Synthesis, Sol-Gel Synthesis, and Microwave Synthesis), Product (Granules, Powders, and Nano-Powders) – Industry Trends and Forecast to 2031.
Bioactive Glass Market Analysis and Size
Bioactive glass market is advancing with innovative uses in bone tissue engineering and wound healing due to its ability to bond with living tissue. The latest methods include tailored compositions for specific medical applications, enhancing bioactivity and biocompatibility. Technologies such as 3D printing enable customized implants. Growth is fueled by increasing demand for biocompatible materials in healthcare, promising a bright future for bioactive glass applications.
The global bioactive glass market size was valued at USD 25.10 billion in 2023 and is projected to reach USD 68.72 billion by 2031, with a CAGR of 6.43% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (45S5, S53P4, and Others), Application (Orthopaedics, Dentistry, Cosmetics, and Others), Industry Vertical (Medical, Dental, and Cosmetics), Synthesis Process (Melt Quench Synthesis, Sol-Gel Synthesis, and Microwave Synthesis), Product (Granules, Powders, and Nano-Powders)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia and New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, United Arab Emirate, Saudi Arabia, Egypt, Israel, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Arthrex, Inc. (U.S.), NORAKER (France), SCHOTT AG (Germany), Stryker (U.S.), Bonalive Biomaterials Ltd. (Finland), British Glass Manufacturers' Confederation (U.K.), MO SCI, LLC (U.S.), LASAK s.r.o. (Czech Republic), Synergy Biomedical, LLC (U.S.), Medical Device Business Services, Inc. (U.S.), MATEXCEL (India), Medtronic (Ireland), NanoFUSE Biologics (U.S.), 3M (U.S.), and Merck KGaA (Germany)
|
|
Market Opportunities
|
|
Market Definition
Bioactive glass is a specialized material designed for biomedical applications. It integrates with living tissue through a process called bioactivity, promoting bone growth and healing. Composed of silica, calcium, phosphorus, and other elements, it mimics the composition of natural bone. Bioactive glass is used in bone grafts, dental fillings, and medical implants due to its biocompatibility and ability to bond with living tissues.
Bioactive Glass Market Dynamics
Drivers
- Increasing Demand in Healthcare
The increasing demand for bioactive glasses in healthcare stems from their pivotal role in bone regeneration and tissue engineering applications. With a rising incidence of bone disorders such as osteoporosis and injuries requiring effective treatment options, bioactive glasses offer crucial solutions. For instance, bioactive glass scaffolds facilitate bone regeneration by releasing ions that stimulate osteogenesis, promoting faster healing and restoration of skeletal integrity. This demand surge underscores bioactive glasses' essentiality in modern medical therapies.
- Biocompatibility and Degradation Properties
The biocompatibility and gradual degradation of bioactive glasses create significant opportunities in medical applications. For instance, in orthopedic surgeries, bioactive glasses promote bone integration by releasing ions such as calcium and phosphate, which stimulate osteogenesis. This capability enhances healing outcomes and reduces the need for additional surgeries, making bioactive glasses preferred for implants and bone grafts. Such advancements drive market growth by meeting critical medical needs with effective and sustainable solutions.
Opportunities
- Advancements in Biomaterials
Advancements in biomaterials have significantly enhanced bioactive glass formulations, boosting their biocompatibility and bioactivity. For instance, researchers have developed bioactive glasses with tailored compositions that mimic bone structure, promoting better integration and healing. These innovations expand their application scope in orthopedic implants, dental fillings, and tissue engineering. Such developments not only improve patient outcomes but also drive market growth by meeting diverse medical needs effectively.
- Innovations in Technology
Technological innovations such as sol-gel techniques and 3D printing are revolutionizing the bioactive glass market by enabling the customization of properties to meet specific medical requirements. For instance, 3D printing allows for the fabrication of complex structures that mimic natural bone geometry, enhancing implant integration. These advancements create opportunities for developing personalized medical solutions, improving patient outcomes, and expanding the application of bioactive glasses in orthopedics, dentistry, and tissue engineering.
Restraints/Challenges
- Limited Awareness and Acceptance
Limited awareness and acceptance of bioactive glasses among healthcare providers and patients compared to traditional materials hinder market penetration. This lack of recognition impedes widespread adoption despite the potential benefits of bioactive glasses in medical applications. Overcoming this challenge requires targeted educational efforts and increased familiarity with the material's capabilities and advantages to build confidence and encourage adoption in the medical community.
- High Cost of Production
The high production costs of bioactive glasses, stemming from specialized materials and manufacturing processes, lead to elevated product prices. This cost barrier restricts adoption, particularly in cost-sensitive markets or applications. Consequently, the bioactive glass market faces challenges in achieving widespread acceptance and penetration, as potential users may seek more affordable alternatives due to these financial constraints.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Recent Developments
- In September 2022, DSM entered a partnership with NutriLeads to co-develop BeniCaros, a bioactive polysaccharide ingredient aimed at enhancing DSM's supplement ingredient manufacturing portfolio. This collaboration seeks to leverage NutriLeads' expertise in nutritional health with DSM's industry-leading capabilities in ingredient innovation. BeniCaros represents a strategic initiative to expand DSM's product offerings, catering to growing consumer demand for effective and sustainable nutritional supplements
Bioactive Glass Market Scope
The market is segmented on the basis of type, industry vertical, synthesis process, product and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- 45S5
- S53P4
- Others
Application
- Orthopaedics
- Dentistry
- Cosmetics
- Others
Industry Vertical
- Medical
- Dental
- Cosmetics
Synthesis Process
- Melt Quench Synthesis
- Sol-Gel Synthesis
- Microwave Synthesis
Product
- Granules
- Powders
- Nano-Powders
Bioactive Glass Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, industry vertical, synthesis process, product and application as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia and New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, United Arab Emirate, Saudi Arabia, Egypt, Israel, South Africa, Rest of Middle East and Africa.
Asia-Pacific is expected to dominate the bioactive glass market, driven by a growing population, rapid urbanization, and improving lifestyles. The region sees rising applications of the product, consolidating its position through technological advancements and increasing healthcare investments, fostering substantial market growth.
North America is expected to show growth in the bioactive glass market, led by the U.S. The region's surge in medical and dental implant expenditures, coupled with rising per capita income, fuels this trend. This growth underscores increasing adoption and investments in advanced healthcare technologies within North America.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Bioactive Glass Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Arthrex, Inc. (U.S.)
- NORAKER (France)
- SCHOTT AG (Germany)
- Stryker (U.S.)
- Bonalive Biomaterials Ltd. (Finland)
- British Glass Manufacturers' Confederation (U.K.)
- MO SCI, LLC (U.S.)
- LASAK s.r.o. (Czech Republic)
- Synergy Biomedical, LLC (U.S.)
- Medical Device Business Services, Inc. (U.S.)
- MATEXCEL (India)
- Medtronic (Ireland)
- NanoFUSE Biologics (U.S.)
- 3M (U.S.)
- Merck KGaA (Germany)
SKU-